|
Minnesota Psychiatric Society Spring Meetings
Saturday, May 3, 2025 7:30am-5:00pm Symposium, 5:00-8:00pm Recognition Dinner Courtyard by Marriott Edina Bloomington Hotel 4460 W 78th Street Circle, Edina, MN 55435 |
Back to the Future: Psychopharmacology
Day Program - 8:00am - 5:00pm
7:30-8:00am – Check-In / Continental Breakfast / Exhibits, Posters
8:00-8:05am – Welcome & Program Overview
MPS President Mark Frye, MD
8:05-8:30am – Plenary Kickoff – Back to the Future Case Discussions
Case discussions at tables (mood, psychosis & addiction) – Back to the Future Case Discussions
8:30-9:45am – Novel antipsychotics and monitoring methods in schizophrenia
Jonathan Leung, PharmD – The Crucial Case for Clozapine and Ensuring Successful Trials
Steve Olson, MD – With the Demise of REMS, Psychiatrists Must Start Prescribing More Clozapine
Felicia Hansell, MD – Novel Antipsychotics and More
9:45-10:00am – Break – Exhibits & Posters
10:00-10:45am – Ketamine/Psilocybin from the 1970’s - 50 years later – Balwinder Singh, MD, MS, FAPA; Sophia Albott, MD
10:45-11:30am – ADHD – Stimulants and beyond – Josh Stein, MD
11:30am-12pm – Poster Session - Poster Session Handout
12:00-1:00pm – Lunch, Networking, Posters & Exhibits
1:00-2:00pm – Flash Talks & Q&A - Facilitator Tracy Tomac, MD; FAPA
– Caylon Pettis, MD (Mayo) – Old vs New Long Acting Injectables
– Christian Morfaw, MD (U of M) – Pharmacologic Treatment of Aggression in Youth with Autism Spectrum Disorder
– Ian Michel, (Mayo) – Female Sex Moderates Association Between Asthma and Earlier Age of Onset in Schizophrenia and Bipolar Disorder
2:00-3:00pm – Drug Mechanism of Action Targeting Addiction & Mood – Mark Frye, MD, Sabrina Corea Da Costa, MD
3:00-3:15pm – Break – Exhibits & Posters
3:15-3:45pm – State of the Art for OUD Medications – Sheila Specker, MD, DFAPA,
– Katie Mackay, MD – 315pm-1 State of the Art for OUD Medications
– Chris Sebas, MD – 315pm-2 Methadone History and Current Use in the Fentanyl Era
3:45-4:30pm – Lithium: Everything Old Is New Again – Tracy Tomac, MD, FAPA
3:45-4:30pm – Plenary Closing Session – Review Morning Discussion, Review & Recap the day; Poster Session Winner Announcements
Evening Program - 5:00 - 8:00pm
5:00-6:30pm – Reception
– President’s Address – MPS President Mark Frye, MD
– Awards Presentations –
7:30-8:00am – Check-In / Continental Breakfast / Exhibits, Posters
8:00-8:05am – Welcome & Program Overview
MPS President Mark Frye, MD
8:05-8:30am – Plenary Kickoff – Back to the Future Case Discussions
Case discussions at tables (mood, psychosis & addiction) – Back to the Future Case Discussions
8:30-9:45am – Novel antipsychotics and monitoring methods in schizophrenia
Jonathan Leung, PharmD – The Crucial Case for Clozapine and Ensuring Successful Trials
Steve Olson, MD – With the Demise of REMS, Psychiatrists Must Start Prescribing More Clozapine
Felicia Hansell, MD – Novel Antipsychotics and More
9:45-10:00am – Break – Exhibits & Posters
10:00-10:45am – Ketamine/Psilocybin from the 1970’s - 50 years later – Balwinder Singh, MD, MS, FAPA; Sophia Albott, MD
10:45-11:30am – ADHD – Stimulants and beyond – Josh Stein, MD
11:30am-12pm – Poster Session - Poster Session Handout
12:00-1:00pm – Lunch, Networking, Posters & Exhibits
1:00-2:00pm – Flash Talks & Q&A - Facilitator Tracy Tomac, MD; FAPA
– Caylon Pettis, MD (Mayo) – Old vs New Long Acting Injectables
– Christian Morfaw, MD (U of M) – Pharmacologic Treatment of Aggression in Youth with Autism Spectrum Disorder
– Ian Michel, (Mayo) – Female Sex Moderates Association Between Asthma and Earlier Age of Onset in Schizophrenia and Bipolar Disorder
2:00-3:00pm – Drug Mechanism of Action Targeting Addiction & Mood – Mark Frye, MD, Sabrina Corea Da Costa, MD
3:00-3:15pm – Break – Exhibits & Posters
3:15-3:45pm – State of the Art for OUD Medications – Sheila Specker, MD, DFAPA,
– Katie Mackay, MD – 315pm-1 State of the Art for OUD Medications
– Chris Sebas, MD – 315pm-2 Methadone History and Current Use in the Fentanyl Era
3:45-4:30pm – Lithium: Everything Old Is New Again – Tracy Tomac, MD, FAPA
3:45-4:30pm – Plenary Closing Session – Review Morning Discussion, Review & Recap the day; Poster Session Winner Announcements
Evening Program - 5:00 - 8:00pm
5:00-6:30pm – Reception
– President’s Address – MPS President Mark Frye, MD
– Awards Presentations –
- 2025 MPS Psychiatrist of the Year Danielle Morgan Goerke, DO
- 2025 Wellstone Award Winner – Representative Danny Nadeau
- Gloria Segal Medical Student Scholarship Winners – Ian Michel & Mario Bertogliat
- 2023-2025 MPS Presidential Service Award – Mary Beth Lardizabal, DO, DFAPA
|
Educational Objectives – At the end of the educational activity, the learner will be able to:
Who Should Attend
This educational activity is intended for psychiatrists, primary care physicians, emergency physicians, psychologists, social workers, physician assistants, registered nurses, advance practice nurses, compliance officers and clinic administrators. All mental health professionals and general health professionals are welcome, including students and residents.
|
Accreditation
In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and the Minnesota Psychiatric Society (MPS). The American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation
The APA designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Exhibitors
Axsome – Bristol Meyer Squibb – Intra-Cellular Therapies, Inc. – Otsuka – Teva Medical
Axsome – Bristol Meyer Squibb – Intra-Cellular Therapies, Inc. – Otsuka – Teva Medical